178 related articles for article (PubMed ID: 9756743)
1. Granulocyte colony-stimulating factor and azole antifungal therapy in murine aspergillosis: role of immune suppression.
Graybill JR; Bocanegra R; Najvar LK; Loebenberg D; Luther MF
Antimicrob Agents Chemother; 1998 Oct; 42(10):2467-73. PubMed ID: 9756743
[TBL] [Abstract][Full Text] [Related]
2. Effect of granulocyte colony-stimulating factor combination therapy on efficacy of posaconazole (SCH56592) in an inhalation model of murine pulmonary aspergillosis.
Patera AC; Menzel F; Jackson C; Brieland JK; Halpern J; Hare R; Cacciapuoti A; Loebenberg D
Antimicrob Agents Chemother; 2004 Aug; 48(8):3154-8. PubMed ID: 15273138
[TBL] [Abstract][Full Text] [Related]
3. SCH56592 treatment of murine invasive aspergillosis.
Graybill JR; Bocanegra R; Najvar LK; Luther MF; Loebenberg D
J Antimicrob Chemother; 1998 Oct; 42(4):539-42. PubMed ID: 9818757
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of SCH56592 in a rabbit model of invasive aspergillosis.
Kirkpatrick WR; McAtee RK; Fothergill AW; Loebenberg D; Rinaldi MG; Patterson TF
Antimicrob Agents Chemother; 2000 Mar; 44(3):780-2. PubMed ID: 10681359
[TBL] [Abstract][Full Text] [Related]
5. Experimental systemic murine aspergillosis: treatment with polyene and caspofungin combination and G-CSF.
Sionov E; Mendlovic S; Segal E
J Antimicrob Chemother; 2005 Sep; 56(3):594-7. PubMed ID: 16006446
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary aspergillosis in mice: treatment with a new triazole SCH39304.
Defaveri J; Salazar MH; Rinaldi MG; Graybill JR
Am Rev Respir Dis; 1990 Sep; 142(3):512-5. PubMed ID: 2202244
[TBL] [Abstract][Full Text] [Related]
7. Polyene and cytokine treatment of experimental aspergillosis.
Sionov E; Segal E
FEMS Immunol Med Microbiol; 2003 Dec; 39(3):221-7. PubMed ID: 14642306
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of human granulocyte colony-stimulating factor (hG-CSF) on Cryptococcus and Aspergillus infections in normal and immunosuppressed mice.
Polak-Wyss A
Mycoses; 1991; 34(5-6):205-15. PubMed ID: 1724550
[TBL] [Abstract][Full Text] [Related]
9. Antifungal activities of posaconazole and granulocyte-macrophage colony-stimulating factor ex vivo and in mice with disseminated infection due to Scedosporium prolificans.
Simitsopoulou M; Gil-Lamaignere C; Avramidis N; Maloukou A; Lekkas S; Havlova E; Kourounaki L; Loebenberg D; Roilides E
Antimicrob Agents Chemother; 2004 Oct; 48(10):3801-5. PubMed ID: 15388437
[TBL] [Abstract][Full Text] [Related]
10. Treatment of experimental murine aspergillosis with BAY n7133.
Graybill JR; Kaster SR; Drutz DJ
J Infect Dis; 1983 Nov; 148(5):898-906. PubMed ID: 6313822
[TBL] [Abstract][Full Text] [Related]
11. Activity of posaconazole combined with amphotericin B against Aspergillus flavus infection in mice: comparative studies in two laboratories.
Najvar LK; Cacciapuoti A; Hernandez S; Halpern J; Bocanegra R; Gurnani M; Menzel F; Loebenberg D; Graybill JR
Antimicrob Agents Chemother; 2004 Mar; 48(3):758-64. PubMed ID: 14982761
[TBL] [Abstract][Full Text] [Related]
12. Role of Granulocyte-Macrophage Colony-Stimulating Factor Signaling in Regulating Neutrophil Antifungal Activity and the Oxidative Burst During Respiratory Fungal Challenge.
Kasahara S; Jhingran A; Dhingra S; Salem A; Cramer RA; Hohl TM
J Infect Dis; 2016 Apr; 213(8):1289-98. PubMed ID: 26908736
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human macrophage colony-stimulating factor augments pulmonary host defences against Aspergillus fumigatus.
Gonzalez CE; Lyman CA; Lee S; Del Guercio C; Roilides E; Bacher J; Gehrt A; Feuerstein E; Tsokos M; Walsh TJ
Cytokine; 2001 Jul; 15(2):87-95. PubMed ID: 11500084
[TBL] [Abstract][Full Text] [Related]
14. Treatment of intra-abdominal abscesses caused by Candida albicans with antifungal agents and recombinant murine granulocyte colony-stimulating factor.
Vonk AG; Netea MG; van Krieken JH; Verweij PE; van der Meer JW; Kullberg BJ
Antimicrob Agents Chemother; 2003 Dec; 47(12):3688-93. PubMed ID: 14638466
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of D0870 compared with those of itraconazole and amphotericin B in two murine models of invasive aspergillosis.
Denning DW; Hall L; Jackson M; Hollis S
Antimicrob Agents Chemother; 1995 Aug; 39(8):1809-14. PubMed ID: 7486923
[TBL] [Abstract][Full Text] [Related]
16.
Kimura G; Nakaoki T; Colley T; Rapeport G; Strong P; Ito K; Kizawa Y
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630185
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of SCH51048 in an experimental model of pulmonary aspergillosis.
Allendoerfer R; Loebenberg D; Rinaldi MG; Graybill JR
Antimicrob Agents Chemother; 1995 Jun; 39(6):1345-8. PubMed ID: 7574528
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus.
Oakley KL; Morrissey G; Denning DW
Antimicrob Agents Chemother; 1997 Jul; 41(7):1504-7. PubMed ID: 9210674
[TBL] [Abstract][Full Text] [Related]
19. Exogenous Stimulation of Type I Interferon Protects Mice with Chronic Granulomatous Disease from Aspergillosis through Early Recruitment of Host-Protective Neutrophils into the Lung.
Seyedmousavi S; Davis MJ; Sugui JA; Pinkhasov T; Moyer S; Salazar AM; Chang YC; Kwon-Chung KJ
mBio; 2018 Mar; 9(2):. PubMed ID: 29588403
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B.
Ozsahin H; von Planta M; Müller I; Steinert HC; Nadal D; Lauener R; Tuchschmid P; Willi UV; Ozsahin M; Crompton NE; Seger RA
Blood; 1998 Oct; 92(8):2719-24. PubMed ID: 9763555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
